Funded Tech Companies

Mirna Therapeutics

Operating out of Austin, Mirna Therapeutics has funding from Pfizer Venture Investments, Celgene and Baxter Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Mirna Therapeutics, Inc. (NASDAQ: MIRN) is a biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics and is the first to establish clinical proof-of-concept for a microRNA replacement therapy for cancer.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/30/2015

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Paul Lammers

        

Chief Financial Officer

Alan Fuhrman

        

Chief Scientific Officer

Miguel Barbosa

        

VP - Finance

Jon Irvin

        

VP - R & D

Jay Stoudemire

        

Company Investors

• Pfizer Venture Investments (Elaine Jones)
• Celgene
• Baxter Ventures (Geeta Vemuri)
• Eastern Capital Limited
• Morningside Group
• New Enterprise Associates (Ed Mathers)
• Correlation Ventures
• Rock Springs Capital
• Osage Partners
• Sante Ventures
• Sofinnova Ventures (Michael Powell)

Browse more funded tech companies:

Mirimus | Miro

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary